Answers are grounded in this paper and cite their sources.
This narrative review assesses novel therapies for improving outcomes in diabetic nephropathy, suggesting collaborative strategies for management.
Diabetic nephropathy (DN) is the leading cause of end-stage kidney disease (ESKD). This narrative review aims to address this gap by critically assessing the long-term effects and effectiveness of novel therapies. The review underscores the necessity of multidisciplinary collaboration to develop effective, safe, and economically viable therapeutic strategies for managing DN.
No takes yet. Share an insight, caveat, or question.
Vedad Herenda (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: